chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Shortness of breath, nausea, anxious 120/80, lungs cer, no wheezing.
COVID infection following COVID vaccine series 01/18, Pfizer, dose #1 02/08, Pfizer dose #2 08/31, Pfizer, dose #2 12/21 COVID swab, result: detected 12/20 pt cc: cough, rhinorrhea, chills, fatigue, myalgias, rhinorrhea, sore throat exposure: co-worker 12/30 clinically resolved
PATIENT RECIEVED HIS VACCINE ON MONDAY OCT 25 2004, ON THURSDAY OCT 28 2004, HE HAD 3 SEIZURES. THE FIRST ONE WAS IN THE MORNING, AND I TOOK HIM TO THE ER, AND THE ER MD TOLD US THAT IT WAS PROBABLY FROM THE PREVNAR VACCINE GIVEN TO HIM MONDAY, AND TO MONITOR HIM FOR ANYMORE REACTIONS. ABOUT 2 HOURS AFTER BEING DISCHARGED FROM THE ER, PATIENT HAD ANOTHER SEIZURE, AND WE RETURNED TO THE ER. HE WAS ADMITTED, AND AT THAT TIME HE HAD DEVELOPED A FEVER. MOTRIN WAS GIVEN. AT AROUND 1130 THAT EVENING, HE HAD A 3RD SEIZURE, AND ONCE AGAIN HAD A FEVER TO GO ALONG WITH IT. TYLENOL WAS GIVEN, AND THE FEVER REDUCED. A CT SCAN AND AN EEG WERE PERFORMED ON HIM TO MAKE SURE THERE WERE NO OTHER UNDERLYING PROBLEMS. ALL TESTS WERE NEGATIVE, AND HE WAS DISCHARGED FROM THE HOSPITAL. Medical record received on 12/15/2004 states pt experienced otitis media, broncho pulmonary dysplasia, status asthmaticus, and status post prematurity. Medical receord received on 12/21/2004 states pt experienced sinusitis. Follow-up: Mom called and reported pt received PREVNAR 10-26-06 - Had 1st seizure 7:40AM Oct 28 went to ER - Released 10:00AM had 2nd seizure 12 noon - went back to ER and was admitted - had 3rd seizure 11:00pm - 10-28-04 at hospital.
Next day had a headache and extremely tired,  Lasted 24 hours; extremely tired; This is a spontaneous report from a contactable consumer. A 73-year-old female patient received first dose of BNT162B2 (BNT162B2) via an unspecified route of administration, administered in Arm Left on 16Feb2021 at 12:45 (Batch/Lot Number: EN9581) as 1ST DOSE, SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had no covid prior to vaccination and was not tested post vaccination. It was reported that the patient next day had a headache and extremely tired, lasted 24 hours and extremely tired on 17Feb2021. No treatment was received for the events. The outcome of the events was recovered on unspecified date.  Follow-up attempts completed. No further information expected.
Lethargy and dizziness lasting several months; Took weekly vitamin B12 shots followed by monthly shots and vitamin D3 supplements; Symptoms gradually improved, still not completely gone.
Upset stomach; Diarrhea; Can't smell; Felt bad; Not feeling well; Nasal congestion; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling well), NASAL CONGESTION (Nasal congestion), FEELING ABNORMAL (Felt bad), ANOSMIA (Can't smell) and ABDOMINAL DISCOMFORT (Upset stomach) in a 66-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension. Concomitant products included HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL HCTZ) for Hypertension, VITAMINS NOS for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced MALAISE (Not feeling well) and NASAL CONGESTION (Nasal congestion). On 01-Mar-2021, the patient experienced FEELING ABNORMAL (Felt bad). On 04-Mar-2021, the patient experienced ANOSMIA (Can't smell). On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (Upset stomach) and DIARRHOEA (Diarrhea). At the time of the report, MALAISE (Not feeling well), NASAL CONGESTION (Nasal congestion), FEELING ABNORMAL (Felt bad), ANOSMIA (Can't smell), ABDOMINAL DISCOMFORT (Upset stomach) and DIARRHOEA (Diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment for the events included none.   This case was linked to MOD-2021-035164 (Patient Link).
immediate incontinence that was permanent, confusion. developed a dark purple area directly above her tailbone that no one could diagnose but in hindsight appeared to be a subcutaneous clot. Extremely high blood pressure. She was taken to a cardiologist on 3 occasions and was given BP meds that were ineffective.  And unbeknown to the cardiologist and myself she was all of a sudden suffering from heart failure that got worse month after month despite going to the emergency room on 4 occasions. They never detected it or ignored it.  I suggested the vaccine but was told it doesn't cause high BP.  We only discovered the heart failure when she went into the hospital after she contracted Covid-19 15 months after the vaccine. There was no indication of heart problems prior to the vaccine The doctor said they noted a large amount of old blood clots throwout her body. We also discovered that she had probable lung cancer that was not there in a routine scan of her chest just prior to her vaccination.  She rapidly declined psychically and mentally in the 15 months following her covid shot until her death despite the many hospital and doctor visits. No one knew what was wrong with her and wouldn't even speculate.
2 weeks after my second booster I started to have strange sensations in my feet an calves. Almost felt like water was running down the inside of my legs. Then my heart began to race and my blood pressure went up to 180/105 and stayed high for weeks (I never have had high blood pressure prior to this). After 4 weeks the blood pressure returned to normal but my leg and foot pain increased to the point that I was in excruciating pain. By end of April (2 months since vaccination) Paresthesia had traveled up my body and into my face. Horrible sensations of burning eruptions everywhere. I made the mistake of getting the 3rd booster in December and it re-ignited the worst of symptoms. I am in 24 hour pain and mental anguish. Constant leg neuropathy. Without pain management, I don't think I would have made it thus far.
On 11/08/04 at approximately 1:00 pm. Mother telephoned HD and stated that 1 child who received Hepatitis  A vaccination had a reaction. Described as being red blotchy marks on back and face. Denied child was experiencing any SOB, dyspnea or dysphagia. Stated that marks did not look like hives or anything else ever seen before. Child was experiencing lightheadedness. Instructed mother to call Physician immediately.
Heavy and painful menstrual cycles; Heavy and painful menstrual cycles; Menstrual cycles now last 14 days in duration.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 07May2021 (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications.  The following information was reported: DYSMENORRHOEA (non-serious), HEAVY MENSTRUAL BLEEDING (non-serious) all with onset 26Apr2021, outcome "not recovered" and all described as "Heavy and painful menstrual cycles"; OLIGOMENORRHOEA (non-serious) with onset 26Apr2021, outcome "not recovered", described as "Menstrual cycles now last 14 days in duration.". Therapeutic measures were not taken as a result of dysmenorrhoea, heavy menstrual bleeding, oligomenorrhoea.  Additional information: The patient did not take any vaccine within four weeks and no other medications within two weeks. The patient did not have covid prior vaccination and had not tested covid post vaccination. The patient had no known allergies. The patient was administered vaccine in a public health clinic.  The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Itchy burning sensation, hives all over body and face, droopy face, and wheezy hard to breath at times.
The patient, began suffering from extreme fatigue about 4 weeks ago and has now been admitted on an emergency basis to Hospital. He has blood clots in his lungs and his heart rate is sustained at approximately 140 beats per minute. No cause for the clots has been determined as of yet and the possibility of the COVID 19 vaccine causing the clots as an adverse effect can not be ruled out. This case needs to be investigated. Patient is still in the hospital as of 5/18/2021.
just a little tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 02Mar2021 16:30 (Lot number: EJ1685) at the age of 54 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset Mar2021, outcome "recovering", described as "just a little tired". Therapeutic measures were not taken as a result of fatigue.  Additional information: The patient has no known allergies. The patient did not receive any other vaccine within 4 weeks prior to COVID-19 vaccine. Prior to vaccination, the patient was not been diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Information has been received from a pharmacist via a company representative referring to a 61 year old female patient. Information concerning medical history and concurrent condition was unspecified. On 20-SEP-2015 (also reported as 2 days ago) the patient was vaccinated with ZOSTAVAX (0.65 ml, lot # K018173, expiry date: 10-JAN-2016, subcutaneous). Concomitant therapies included Influenza virus vaccine inactivated (manufacturer unknown). On 22-SEP-2015 (also reported as yesterday), the patient experienced redness at the site of injection. The size of the redness was like an egg. On 22-SEP-2015, in the middle of the redness, there was also an approximately nickel size blister that was raised approximately an 1/2 inch and was filled with fluid. On the same day the redness itched a little bit. The patient had called the reporting pharmacist for medical attention. No treatment was given for the events. The outcome of the events was unknown. Additional information has been requested.
Expired vaccine administered to patient; date of expiry 01APR2022, Store in refrigeration on 4APR2022, Date of administration 5Apr2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient) and PRODUCT STORAGE ERROR (date of expiry 01APR2022, Store in refrigeration on 4APR2022, Date of administration 5Apr2022) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-Apr-2022, the patient experienced PRODUCT STORAGE ERROR (date of expiry 01APR2022, Store in refrigeration on 4APR2022, Date of administration 5Apr2022). On 05-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient) and PRODUCT STORAGE ERROR (date of expiry 01APR2022, Store in refrigeration on 4APR2022, Date of administration 5Apr2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  The Pharmacist was calling to verify an expiration date for lot number 026L21B. The pharmacist said that when his Pharmacy received this vaccine on 23FEB2022 that a Pharmacy staff member looked up the expiration date and came up with an expiration date of June 2022. However another Pharmacy Staff member looked up the expiration date of the Moderna Covid-19 vaccine in question and the expiration date is 01APR2022. Number of doses/vials: 80 doses administered. The vial did not undergo any temperature excursions. Caller mentioned 155 patients where vaccinated with expired doses from 2Apr2022 to 19Apr2022. The Pharmacist did not have any other information on the patients at this time.  Treatment medications were not reported.
had sx 27 hours after 2nd vaccine of red raised rash  on back, chest and upper neck, itchy, swollen lymph nodes on neck and both arm pits on 2/2, very fatigue
Information has been received from a physician via a company representative referring to a 66 year old female patient. Information concerning medical history and concurrent condition was not reported. On an unknown date the patient was vaccinated with PNEUMOVAX 23 (0.5 ml, once, intramuscular). There was no concomitant therapy. On an unknown date the patient experienced pain at the injection site. The injection site was also red and swollen. The patient had contacted the physician for medical attention. The patient was treated with unspecified antibiotics and was scheduled for a follow up visit with the physician 26-OCT-2015. The outcome of the events was unknown. Additional information has been requested.
Initial consumer report received on 22 Dec 2009: This patient was vaccinated with FLUVIRIN on an unspecified date. The patient initiated DIOVAN (date, dosage and indication unspecified) approximately one and half years ago. Last week, after she received her flu shot she experienced hallucinations, which lasted a couple of days. The outcome of event was not reported.
high grade fever of 105F; Extreme discomfort; Muscle Pain; This case was reported by a pharmacist via call center representative and described the occurrence of fever in a 51-year-old female patient who received Herpes zoster (Shingrix) (batch number 47D2Z, expiry date 24th April 2022) for prophylaxis.   On 30th July 2020, the patient received the 1st dose of Shingrix. On 31st July 2020, 1 days after receiving Shingrix, the patient experienced fever, discomfort and muscle pain. On an unknown date, the outcome of the fever, discomfort and muscle pain were unknown.   It was unknown if the reporter considered the fever, discomfort and muscle pain to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient experienced high grade fever of 105 degree F after receiving the 1st dose of Shingrix, next day development of symptoms. The patient also reported the patient complaint of extreme discomfort and muscle pain. The Pharmacist reported that he advised the patient to seek medical care at a local Emergency Room.The patient had not sought medical treatment at the time of the report. The reporter consent to follow up. This case has been linked with case US2020148712, reported by the same reporter.; Sender's Comments: A Pharmacist reported that a patient developed a high grade fever of 105F after receiving  the 1st dose of Shingrix. (next day development of symptoms) . He also reported the patient complaint of extreme discomfort and muscle pain.The Pharmacist reported that he advised the patient to seek medical care at a local Emergency Room.The patient had not sought medical treatment at the time of the report.  Consented to follow up. "The Vaccine Administration Facility is the same as Primary Reporter", US-GLAXOSMITHKLINE-US2020148712:same reporter
Starting the night of vaccination aching Pain radiating from shoulder to fingertips in left arm, that patient describes as her arm being sawed in half. Patient states she could not sleep that night because the pain was so intense. Patient has been taking 400 mg Ibuprofen every 4 hours since pain started. Vaccinations had to be put in left arm due to mastectomy in right arm. Patient states her tender spot is 2 finger widths below shoulder in outer deltoid. Vaccinations given 9/26/18 and still complaining of pain on 9/29/18. Patient called her orthopedist but the nurse there told her the pain in her shoulder was probably not related to the immunizations.
Extreme swelling & redness at site of injection the size of a baseball, increased to size of a football, extreme pain & limited movement, slight fever.
EMS reported patient with elevated BP, pale and sweating (flu-like symptoms). Doctor's office called and said that he was fine. I called later that day and the father said he was fine.
On 1-13 in am got this severe headache after eye drop. Went to eye Dr. AM of 14th - eye pressure fine - Blood pressure high. Saw family Dr. and had head SCAN, that was fine. Have in AM seen internist and cardiology Dr.. Continued high BP being treated.
Case number PHEH2014US019156, is an initial spontaneous report received from a nurse on 19 Sep 2014. This report refers to a 64-year-old male patient. Past medical history and concomitant medication was not reported. On 18 Sep 2014, the patient was inadvertently vaccinated with FLUVIRIN (batch number: 1412001) intramuscularly at a dose of 1.0 ml instead of the recommended 0.5 ml dose. No adverse event was reported following this medication error (overdose).
Patient complained of severe pain (8/10)  in right arm that radiated to scapula and chest.  Pain improved to a 5/10 in his arm.
Patient c/o swelling lymph nodes and a swelling feeling in her throat after 3rd Rabies vaccine - worse after 4th in the series
Significant erythema and swelling at the injection site location. Patient reports pain and hot to touch. Approximately 2-3 inches in diameter. Advised patient to report to urgent care for evaluation.
1 week after 1St vaccine my knee started to be really painful. went to doc and PT was almost better.  Then received 2nd shot and the pain on the knee is WORSE.  PT says ligament damage Hard to walk and have never had anything like this before and did not hurt or damage my knee through sports etc
FLUZONE PFS, that were expired was administered with no reported Adverse Event; Initial information received on 10-Oct-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 8 years old male patient who was administered expired influenza quadrival A-B vaccine [Fluzone QIV] with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received suspect influenza quadrival A-B vaccine suspension for injection standard at a dose of 0.5 ml once (lot UT7378MA, expiry date- 30-Jun-2022) via intramuscular route in the right deltoid for immunization.  On 07-Oct-2022 the patient was administered expired influenza quadrival A-B vaccine with no reported adverse event (expired product administered) (unknown latency) following the administration of vaccine.  Action taken with influenza quadrival A-B vaccine was not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Developed a red, hot, slightly elevated spot on the back of arm that received injection on day 14 post vaccination (yesterday).  Patient marked area with a pen, to see if it spread overnight.  Area did spread and was approx. 9cm x 9cm today when reported to pharmacy.
By mistake I gave the patient Hepatitis B and PEDIARIX (DTap-HepB-IPV).
Patient's daughter reports that ever since patient received the vaccine she has been intermittently ill. She has experienced general malaise and vomiting for a few days, then recovers, then gets ill again. The cycle has repeated about 3 times since her vaccination. Advised patient to make an appointment with her doctor to rule out any other contributing causes.
Shivers; fatigue; blood pressure is 154/127; This case was reported by a consumer via call center representative and described the occurrence of shivers in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 25th October 2022, the patient received Shingles vaccine. In October 2022, less than a week after receiving Shingles vaccine, the patient experienced shivers, fatigue and blood pressure high. On an unknown date, the outcome of the shivers, fatigue and blood pressure high were not recovered/not resolved.   It was unknown if the reporter considered the shivers, fatigue and blood pressure high to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 26-OCT-2022 Reporter's Comment: The case was reported by the patient. The patient received a shingles shot the day before reporting. The patient had experienced shivers, fatigue and his/her blood pressure was 154/127.  The reporter wanted to know if it was normal. Additional Supportive Information: The follow up would not possible as no contact details were available.
Prior to receiving  Pfizer vaccine, I had mild tinnitus, which did not bother me during the day with normal ambient sounds and I was able to drown it out with a fan running at night bedside. It is now much more noticeable during the day and the fan is not as effective.  At times, during the day, I need to turn on music or something to drown out the ringing.
Injection site started to swell 90 minutes after injection and became itchy. Patient said the site became swollen to the size of a baseball. She iced the injection site and was instructed to take cetirizine on 9/17/14 by a nurse at her place of work. She said the injection site continued to flare up and flare down for about 4 days.
I felt weakness in my legs; twitching in both legs; I got my second Pfizer shot, last Wednesday, about 6 weeks after my first shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administered in arm left, administration date 15Sep2021 (Lot number: FC3184) as dose 2, single for covid-19 immunisation. Relevant medical history included: "COVID", start date: Nov2020 (unspecified if ongoing), notes: I had COVID (Further Clarifications Unknown) last year in November. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose 1), administration date: 26Jul2021, for COVID-19 immunisation. The following information was reported: ASTHENIA (non-serious) with onset 20Sep2021, outcome "not recovered", described as "I felt weakness in my legs"; MUSCLE TWITCHING (non-serious) with onset 20Sep2021, outcome "not recovered", described as "twitching in both legs"; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 15Sep2021, outcome "unknown", described as "I got my second Pfizer shot, last Wednesday, about 6 weeks after my first shot". The events "i felt weakness in my legs" and "twitching in both legs" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of asthenia, muscle twitching.  No follow-up attempts are possible. No further information is expected.